The breast cancer screening programmes in the United Kingdom currently invite women
aged 50–70 years for screening mammography every 3 years. Since the time the screening …

Population-based screening for early detection and treatment of colorectal cancer (CRC)
and precursor lesions, using evidence-based methods, can be effective in populations with …

Background Colonoscopy and sigmoidoscopy provide protection against colorectal cancer,
but the magnitude and duration of protection, particularly against cancer of the proximal …

Background In randomized trials, fecal occult-blood testing reduces mortality from colorectal
cancer. However, the duration of the benefit is unknown, as are the effects specific to age …

Background: Lung cancer is the leading cause of cancer-related death in the United States.
Because early-stage lung cancer is associated with lower mortality than late-stage disease …

Answer questions and earn CME/CNE Each year the American Cancer Society (ACS)
publishes a summary of its recommendations for early cancer detection, a report on data …

There is increasing evidence that faecal immunochemical tests (FITs) for haemoglobin offer
a number of advantages over traditional guaiac based faecal occult blood tests (gFOBTs) …

Cancer vaccines based on human tumor-associated antigens (TAA) have been tested in
patients with advanced or recurrent cancer, in combination with or following standard …

Background Colorectal cancer is the third most frequent cancer in the world. As the sojourn
time for this cancer is several years and a good prognosis is associated with early stage …

Objective: The main objective of this study was to investigate the potential use of circulating
microRNAs (miRNAs) as biomarkers of colorectal (CR) adenomas. Background: Detection of …